Financing channel feed – Endpoints News

Financing channel feed

Medicxi is rolling out its biggest fund ever to back Europe's top 'scientists with strange ideas'

6 years ago

Biotech unicorns first to go as Neil Woodford auctions assets off suspended fund — report

6 years ago

Denmark's Genmab hits the jackpot with $500M+ US IPO as smaller biotechs rake in a combined $147M

6 years ago

Backed by some of the biggest names in biotech, Norbert Bischofberger gets his megaround for platform tech out of MIT

6 years ago

Following footsteps of chart-topping Chinese counterparts, Alphamab Oncology files IPO at HKEX

6 years ago

Bayer, Longwood back star researcher's deep dive into the tumor microenvironment for new I/O targets

6 years ago

Part club, part guide, part landlord: Arie Belldegrun is blueprinting a string of bespoke biotech complexes in global boomtowns — starting with Boston

6 years ago

San Diego ophthalmic biotech upstart raises $28M on alternative to corneal transplant

6 years ago

AM-Pharma gathers €116M for PhIII program on kidney drug Pfizer passed on

6 years ago

Peter Kolchinsky and Raj Shah raise a $300M fund devoted to biotech startups

6 years ago

Billing itself as the first AI biotech to launch human trials, Recursion adds $121M C round

6 years ago

Sofinnova lends AbiVax a hand for PhII anti-inflammatory trials, picking up €12M worth of stock

6 years ago

Genmab steps up for a $500M IPO haul, with its sights on a record-setting market cap

6 years ago

In a first, HKEX receives IPO pitch from local biotech looking to make it big in crowded antibodies field

6 years ago

Third Rock cancer startup Revolution Medicines scores $100M in fresh raise

6 years ago

Trade tensions are impeding the flow of Chinese money to US biotechs — but how much?

6 years ago

ADC Therapeutics has raised $550M-plus in its quest for their first BLA — and here’s why that’s important

6 years ago

German cancer biotech BioNTech raises a mammoth $325M in latest round, bringing total haul to $1.4B+

6 years ago

IGM Biosciences banks a $103M megaround on its quest to pioneer a new kind of cancer-fighting antibody

6 years ago

Medicxi, Taiho infuse €30M into Evotec spinout — eyeing cancer meds targeting DNA damage response pathways

6 years ago

SV joins CRUK on a $250M-plus fund with an eye on developing new cancer drugs

6 years ago

Investors trapped for another 28 days as suspension of Woodford flagship fund drags on

6 years ago

Bayer, Versant back a $250M cell therapy startup on a quest to create off-the-shelf immuno-oncology therapies

6 years ago

Neil Woodford refreshes portfolio with fire sale while investors ponder future of suspended fund

6 years ago

First page Previous page 110 111 112113114 115 116 Next page Last page